je.st

Home › dosing

Tag: dosing

Pumps Offer Low Flow, Accurate Dosing

2014-11-11 07:02:04| Chemical Processing

Moyno introduced a new range of dosing pumps for applications where low flow, accurate dosing is required.

Batch Processing Controller automates dosing and dispensing.

2014-08-22 14:33:14| Industrial Newsroom - All News for Today

By automating batch-out processing, Model 1020-B™ eliminates need for operator to visually monitor dosing and dispensing processes. Controller monitors single channel using loop-powered, programmable output of 4-20 mA. Overall system accuracy is 0.1–0.25% FS capacity. Recommended for use with drum, tank, platform, and stainless steel platform scale bases, controller operates using 6-button panel with indicator lights and provides accurate readings to 5 digits on 2-line, backlit, alphanumeric LCD. This story is related to the following:Process Controls | Batch Controllers

Tags: processing controller batch dispensing

VJIKKS ENGG POWER Installs Chlorine Gas Dosing System for 5N Plus, Canada

2014-06-12 13:40:00| Power Technology

VJIKKS ENGG POWER has installed a chlorine gas dosing system for 5N Plus, Canada, the worlds leading special metal producer.

Tags: system plus power canada

First Patient Enrolled in New Phase 3 Trial Program Investigating a Once-Daily Dosing Regimen of ISENTRESS (raltegravir)

2014-06-05 23:00:00| Merck.com - Research & Development News

Dateline City: WHITEHOUSE STATION, N.J. ONCEMRK Study Globally Enrolling Treatment-Nave Adults with HIV-1 WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the first patient has been enrolled in the companys global Phase 3 clinical trial, ONCEMRK. ONCEMRK is assessing a once-daily investigational formulation of ISENTRESS (raltegravir), known as reformulated raltegravir, as part of combination HIV therapy for treatment-nave HIV-1-infected adults. Language: English Contact: MerckMedia Contacts:Caroline Lappetito, 267-305-7639Sarra Herzog, 908-423-6154orInvestor Contacts:Carol Ferguson, 908-423-4465Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: of program trial phase